BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6741250)

  • 1. [Radioimmunochemical analysis in the evaluation of the effectiveness of drug therapy of breast cancer in women of reproductive age].
    Tkacheva GA; Moroz LV; Ivanov VM
    Vestn Akad Med Nauk SSSR; 1984; (5):54-60. PubMed ID: 6741250
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dynamics of calcitonin, prolactin and carcino-embryonic antigen during the treatment of breast cancer in menopausal patients].
    Tkacheva GA; Moroz LV; Polevaia EB
    Vestn Akad Med Nauk SSSR; 1984; (10):88-94. PubMed ID: 6506860
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possibility of using tumor markers, pituitary gonadotropic hormones and prolactin in the diagnosis of breast cancer].
    Korolev VI; Skliar SIu; Chebotareva ED; Akimova RN
    Vopr Onkol; 1986; 32(11):55-9. PubMed ID: 3788082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical aspects of the radioimmunoassay of carcinoembryonic antigen levels in breast cancer].
    Agranat VZ; Baliura AV; Nikogosian GA; Smolina TA; Iass NIa
    Med Radiol (Mosk); 1983 Aug; 28(8):34-7. PubMed ID: 6888209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour markers in breast cancer.
    Br Med J; 1979 Apr; 1(6170):1036. PubMed ID: 444912
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperprolactinemia in metastasizing breast cancer].
    Nagel GA; Wander HE; Blossey HC
    Schweiz Med Wochenschr; 1981 Dec; 111(50):1977-9. PubMed ID: 7330651
    [No Abstract]   [Full Text] [Related]  

  • 7. Slope analysis of plasma carcinoembryonic antigen levels in monitoring response to treatment in patients with metastatic carcinoma of the breast.
    Koch M; Paterson AH; McPherson TA
    Clin Oncol; 1980 Dec; 6(4):323-7. PubMed ID: 7460406
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in carcinoembryonic antigen in patients with breast cancer].
    Papaleo G; Zito GA; Gambardella A; Colella C
    Boll Soc Ital Biol Sper; 1982 Dec; 58(23):1577-81. PubMed ID: 7165764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carcinoembryonic antigen and breast cancer].
    Wittekind C
    Verh Dtsch Ges Pathol; 1985; 69():194-203. PubMed ID: 3913194
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of "5-drug" treatment of advanced breast cancer].
    Dorociak R
    Pol Tyg Lek; 1981 Sep; 36(38):1467-70. PubMed ID: 7329862
    [No Abstract]   [Full Text] [Related]  

  • 11. [Carcinoembryonic antigen in breast tumors: initial evaluation and monitoring].
    Bolla M; Daidj H; Lachet B; Bouchet Y; Vrousos C
    Bull Cancer; 1983; 70(4):300-2. PubMed ID: 6652251
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer trends: surgical adjuvant chemotherapy for operable breast cancer.
    Horsley JS; Diasio RB
    Va Med; 1980 Nov; 107(11):781-4. PubMed ID: 7434892
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of a radioimmunologic analysis method in oncologic examinations of high-risk groups].
    Chebotareva ED; Skliar SIu
    Vrach Delo; 1986 May; (5):5-8. PubMed ID: 3727508
    [No Abstract]   [Full Text] [Related]  

  • 14. [Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)].
    Di Martino G; Iannucci F; Bizzarro A; Iacono G
    Boll Ist Sieroter Milan; 1982; 61(5):411-22. PubMed ID: 6985416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II Study of AMSA, prednisone, and chlorambucil (APC) in the treatment of refractory breast cancer: a Northern California Oncology Group Study.
    Friedman MA; Marcus F; Kohler M; Resser KJ
    Cancer Treat Rep; 1982 May; 66(5):1235-6. PubMed ID: 7083225
    [No Abstract]   [Full Text] [Related]  

  • 16. New regimen of combination hormone therapy (ME-TA-MAP) in the treatment of advanced breast cancer. A pilot study.
    Pannuti F; Martoni A; Fruet ; Marraro D; Strocchi E
    Panminerva Med; 1981; 23(3):157-60. PubMed ID: 7335366
    [No Abstract]   [Full Text] [Related]  

  • 17. A pilot study of a high dose methotrexate regime in the management of advanced breast cancer.
    Penney GC; Roberts MM
    Clin Oncol; 1980 Dec; 6(4):385-6. PubMed ID: 7460412
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy in advanced breast cancer: experience in 100 cases (author's transl)].
    Modolell Roig A; Sans-Sabrafen J; Pardo Peret P; Rodríguez Ferrera JC; Boleda Relats M; Buxó Costa J; Galofré Folch M
    Med Clin (Barc); 1982 Mar; 78(6):211-7. PubMed ID: 7087579
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy in breast cancer].
    Hoang Palangie T
    Soins Gynecol Obstet Pueric; 1981 May; (4):19-22. PubMed ID: 6910911
    [No Abstract]   [Full Text] [Related]  

  • 20. Biologic markers and breast cancer.
    Waalkes TP; Tormey DC
    Semin Oncol; 1978 Dec; 5(4):434-44. PubMed ID: 83677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.